Some Washington long-term care facilities have yet to receive COVID-19 vaccine

Preparations are currently being made throughout Washington state for the latest phase in vaccine distribution, called phase 1b. However, some front-line healthcare workers are concerned that they have no idea when they'll get the vaccine in the state's current phase, 1a.

Who's getting the COVID-19 vaccine next: A look at Washington's distribution plan

The Washington State Department of Health has announced that the next group in line to receive the coronavirus vaccine will be those who are aged 65 and older and those 50 years and older who live in multi-generational homes.

Coronavirus means life won't go back to normal until fall 2021, despite vaccines: Fauci

Top White House coronavirus adviser Dr. Anthony Fauci said Thursday that life in the U.S. will not get back to normal until fall 2021 despite emergency approvals of vaccines.

COVID-19 timeline: How the pandemic unfolded over 1 year

The challenging months brought death, sickness, disruption and scientific exploration to the forefront of our lives, and many call it both the shortest and the longest year in history — and one that will certainly not be forgotten.

Health officials track safety as COVID-19 vaccines roll out

On Tuesday, a health worker in Alaska suffered a severe allergic reaction after receiving the Pfizer COVID-19 vaccine.

Healthcare systems ready to vaccinate, but some people still hesitant

UW is strongly encouraging employees to schedule the vaccine right before having a day or two off so they can monitor for potential symptoms from home.

FDA to livestream public meeting on Pfizer-BioNTech potential COVID-19 vaccine

The U.S. Food and Drug Administration has set a public meeting on Dec. 10 to discuss approving Pfizer and BioNTech’s experimental COVID-19 vaccine and will livestream it on YouTube, Facebook and Twitter.

AstraZeneca plans to deliver vaccine trial data by year's end

AstraZeneca hopes to show its COVID-19 vaccine is effective by the end of this year and is ramping up manufacturing so it can supply hundreds of millions of doses in January, Chief Executive Pascal Soriot said Thursday.